The suppression of apoptosis by α-herpesvirus

Yu You1,2,3, An-Chun Cheng1,2,3, Ming-Shu Wang1,2,3

  • 1Institute of Preventive Veterinary Medicine, Sichuan Agricultural University, Wenjiang, Chengdu City 611130, Sichuan, P.R. China.

Cell Death & Disease
|April 14, 2017
PubMed

Insights

Alpha-herpesviruses employ sophisticated anti-apoptotic strategies to evade host defenses and promote viral replication. Understanding these mechanisms could lead to new therapeutic targets for herpesvirus infections.

Area of Science:

  • Immunology
  • Virology
  • Molecular Biology

Background:

  • Apoptosis is a crucial immune mechanism for eliminating infected cells, primarily regulated by death receptor and mitochondria-mediated pathways.
  • Viruses, including alpha-herpesviruses, have evolved mechanisms to suppress apoptosis, aiding their propagation and immune evasion.
  • Alpha-herpesvirus utilizes a complex anti-apoptotic strategy throughout its life cycle.

Purpose of the Study:

  • To review the current understanding of apoptosis inhibition by alpha-herpesvirus.
  • To elucidate the mechanisms employed by alpha-herpesvirus anti-apoptotic genes and their products.
  • To discuss future therapeutic strategies targeting herpesvirus-induced apoptosis suppression.

Main Methods:

  • Review of existing literature on alpha-herpesvirus and apoptosis.
  • Analysis of molecular mechanisms underlying viral anti-apoptotic gene function.
  • Discussion of potential therapeutic interventions.

Main Results:

  • Alpha-herpesviruses encode specific anti-apoptotic factors.
  • These factors interfere with key components of the apoptotic signalling pathways.
  • The virus actively manipulates host cell death pathways for its benefit.

Conclusions:

  • Alpha-herpesvirus possesses multifaceted strategies to inhibit apoptosis.
  • Targeting these viral anti-apoptotic functions presents a promising therapeutic avenue.
  • Further research is needed to fully exploit these mechanisms for clinical application.

Related Concept Videos

Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Herpes01:28

Herpes

Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...